Morbidity of selective lymph node biopsy for melanoma: Meta-analysis of complications

Tumori

Volumn 98, Issue 1, 2012, Pages 94-98

  Cigna, Emanuele ^a   Gradilone, Angela ^b   Ribuffo, Diego ^c   Gazzaniga, Paola ^b   Fino, Pasquale ^a   Sorvillo, Valentina ^a   Scuderi, Nicolò ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Melanoma; Postoperative morbidity; Radical lymphadenectomy; Sentinel lymph node; Sentinel lymph node biopsy

Indexed keywords

ARTICLE; CANCER STAGING; CLINICAL EVALUATION; FOLLOW UP; HEMATOMA; HUMAN; KELOID; LYMPH NODE METASTASIS; LYMPHEDEMA; MELANOMA; META ANALYSIS; MORBIDITY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PAIN; SENTINEL LYMPH NODE BIOPSY; SEROMA; SURGICAL INFECTION; TUMOR LOCALIZATION; ARM; AXILLA; INGUINAL REGION; LEG; LYMPH NODE; NECK; PATHOLOGY; SKIN TUMOR;

AXILLA; FOLLOW-UP STUDIES; GROIN; HEMATOMA; HUMANS; KELOID; LOWER EXTREMITY; LYMPH NODES; LYMPHATIC METASTASIS; LYMPHEDEMA; MELANOMA; MORBIDITY; NECK; NEOPLASM STAGING; PAIN, POSTOPERATIVE; SENTINEL LYMPH NODE BIOPSY; SEROMA; SKIN NEOPLASMS; SURGICAL WOUND INFECTION; UPPER EXTREMITY;

EID: 84863192749     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1177/030089161209800113     Document Type: Article

References (27)

1. Scheri RP, Essner R: Lymphatic mapping and sentinel lymphadenectomy in primary cutaneous melanoma. Expert Rev Anticancer Ther, 6: 1105-1110, 2006. [Review] (Pubitemid 44203387)
2. Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, Foshag LJ, Cochran AJ: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg, 127: 392-399, 1992.
3. Cochran AJ, Wen DR, Morton DL: Management of the regional lymph nodes in patients with cutaneous malignant melanoma. World J Surg, 16: 214-221, 1992.
4. Thompson JF, McCarthy WH, Bosch CM, O'Brien CJ, Quinn MJ, Paramaesvaran S, Crotty K, McCarthy SW, Uren RF, Howman-Giles R: Sentinel lymph node status as an indicator of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res, 5: 255-260, 1995.
5. Morton DL, Thompson JF, Essner R, Elashoff R, Stern SL, Nieweg OE, Roses DF, Karakousis CP, Mozzillo N, Reintgen D, Wang HJ, Glass EC, Cochran AJ: Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg, 230: 453-465, 1999. (Pubitemid 30191840)
6. Kelley MC, Hansen N, McMasters KM: Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Am J Surg, 188: 49-61, 2004. (Pubitemid 38823055)
7. Wilke LG, McCall LM, Posther KE, Whitworth PW, Reintgen DS, Leitch AM, Gabram SG, Lucci A, Cox CE, Hunt KK, Herndon JE 2nd, Giuliano AE: Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol, 13: 491-500, 2006.
8. El-Ghobashy AE, Saidi SA: Sentinel lymph node sampling in gynaecological cancers: techniques and clinical applications. Eur J Surg Oncol, 35: 675-685, 2009.
9. Wu H, Xu X, Ying H, Hoffman MR, Shen N, Sha Y, Zhou L: Preliminary study of indirect CT lymphography-guided sentinel lymph node biopsy in a tongue VX2 carcinoma model. Int J Oral Maxillofac Surg, 12: 1268-1272, 2009.
10. Tan K, Kawamura Y, Mizokami K, Sasaki J, Tsujinaka S, Maeda T, Nobuki M, Konishi F: Distribution of the first metastatic lymph node in colon cancer and its clinical significance. Colorectal Dis, 12: 44-47, 2010.
11. De Vries M, Vonkeman WG, van Ginkel RJ, Hoekstra HJ: Morbidity after axillary sentinel lymph node biopsy in patients with cutaneous melanoma. Eur J Surg Oncol, 31: 778-783, 2005. (Pubitemid 41194657)
12. Swenson KK, Nissen MJ, Ceronsky C, Swenson L, Lee MW, Tuttle TM: Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann Surg Oncol, 9: 745-753, 2002.
13. Wrightson WR, Wong SL, Edwards MJ, Chao C, Reintgen DS, Ross MI, Noyes RD, Viar V, Cerrito PB, McMasters KM; Sunbelt Melanoma Trial Study Group: Complications associated with sentinel lymph node biopsy for melanoma. Ann Surg Oncol, 10: 676-680, 2003. (Pubitemid 40486900)
14. Wasserberg N, Tulchinsky H, Schachter J, Feinmesser M, Gutman H: Sentinel-lymph-node biopsy (SLNB) for melanoma is not complication-free. Eur J Surg Oncol, 30: 851-856, 2004. (Pubitemid 39186072)
15. Schrenk P, Rieger R, Shamiyeh A, Wayand W: Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer, 88: 608-614, 2000. (Pubitemid 30056936)
16. Blanchard DK, Donohue JH, Reynolds C, Grant CS: Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg, 138: 482-487, 2003.
17. Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Robertson C, Maisonneuve P, Renne G, De Cicco C, De Lucia F, Gennari R: A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med, 349: 546-553, 2003. (Pubitemid 36951366)
18. Haid A, Kuehn T, Konstantiniuk P, Köberle-Wührer R, Knauer M, Kreienberg R, Zimmermann G: Shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer. Eur J Surg Oncol, 28: 705-710, 2002. (Pubitemid 36240568)
19. Morton DL, Chan AD: The concept of sentinel node localization: how it started. Semin Nucl Med, 30: 4-10, 2000. (Pubitemid 30059084)
20. Gradilone A, Gazzaniga P, Ribuffo D, Scarpa S, Cigna E, Vasaturo F, Bottoni U, Innocenzi D, Calvieri S, Scuderi N, Frati L, Aglianò AM: Survivin, bcl-2, bax, and bcl-X gene expression in sentinel lymph nodes from melanoma patients. J Clin Oncol, 21: 306-312, 2003. (Pubitemid 46606160)
21. Ribuffo D, Gradilone A, Vonella M, Chiummariello S, Cigna E, Haliassos N, Massa R, Silvestri I, Calvieri S, Frati L, Aglianò AM, Scuderi N: Prognostic significance of reverse transcriptase-polymerase chain reaction-negative sentinel nodes in malignant melanoma. Ann Surg Oncol, 10: 396-402, 2003. (Pubitemid 40486937)
22. Gradilone A, Ribuffo D, Silvestri I, Cigna E, Gazzaniga P, Nofroni I, Zamolo G, Frati L, Scuderi N, Aglianò AM: Detection of melanoma cells in sentinel lymph nodes by reverse transcriptase-polymerase chain reaction: prognostic significance. Ann Surg Oncol, 11: 983-987, 2004. (Pubitemid 40486664)
23. Gradilone A, Gazzaniga P, Cigna E, Vasaturo F, Vincenzi B, Gandini O, Silvestri I, Ribuffo D, Scarpa S, Scuderi N, Aglianò AM: Fibronectin and laminin expression in sentinel lymph nodes of patients with malignant melanoma. Br J Dermatol, 157: 398-401, 2007. (Pubitemid 47083845)
24. Gazzaniga P, Cigna E, Vincenzi B, Bottoni U, Vasaturo F, Alfano C, Calvieri S, Frati L, Scuderi N, Aglianò AM, Gradilone A: Tenascin C: a defensive role in sentinel lymph nodes of melanoma patients? J Dermatol Sci, 53: 239-241, 2009.
25. Leong SP, Steinmetz I, Habib FA, McMillan A, Gans JZ, Allen RE Jr, Morita ET, el-Kadi M, Epstein HD, Kashani-Sabet M, Sagebiel RW: Optimal selective sentinel lymph node dissection in primary malignant melanoma. Arch Surg, 132: 666-673, 1997. (Pubitemid 27255614)
26. Hettiaratchy SP, Kang N, O'Toole G, Allan R, Cook MG, Powell BW: Sentinel lymph node biopsy in malignant melanoma: a series of 100 consecutive patients. Br J Plast Surg, 53: 559-562, 2000.
27. Neville HL, Andrassy RJ, Lally KP, Corpron C, Ross MI: Lymphatic mapping with sentinel node biopsy in pediatric patients. J Pediatr Surg, 35: 961-964, 2000. (Pubitemid 30346196)